INTRODUCTION AND OBJECTIVES: Radical prostatectomy (RP), external-beam radiotherapy (EBRT), and brachytherapy are standard treatments for localized prostate cancer but each may negatively impact bowel function. We sought to develop a nomogram predicting the probability of treatment-related bowel problems using prospective, patient-reported data.
METHODS: Patient-reported data on treatment-related bowel problems was obtained from four prospective, longitudinal, healthrelated quality-of-life (HRQOL) protocols comprising 2,668 patients treated between 1999 and 2011 in the United States and Spain. A single HRQOL instrument was not uniformly used for each study, though a similar 5-point scale was used in each protocol to assess bother related to bowel problems. Bowel dysfunction was defined as bowel symptoms identified as a moderate-to-big problem by patients on survey responses before treatment and 2 years post-treatment. Multivariable logistic regression analysis was used to model the clinical information and follow-up data. Internal validation was performed using bootstrapping.
RESULTS: Overall, 43 patients (2%) with complete data had bowel dysfunction prior to treatment. The rate of bowel dysfunction at 2 years in patients with no bowel dysfunction pretreatment was 2%, 10%, and 4% for patients treated by RP, EBRT, and brachytherapy, respectively (p<0.001). A nomogram based on pretreatment bowel bother, treatment modality, and race had a concordance index of 0.725 and predictions were well-calibrated with observed outcome on cross-validation. The predictive accuracy was not increased by the inclusion of additional demographic, tumor-related, or treatmentrelated variables, or by the creation of separate treatment-specific models.
CONCLUSIONS: A validated nomogram that predicts 2-year probability of bowel dysfunction after treatment for localized prostate cancer has been developed. The nomogram is anticipated to be useful for patient counseling regarding treatment options for localized prostate cancer. 
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INTRODUCTION AND OBJECTIVES:
To evaluate the risk factors of acute urinary retention (AUR) following robot-assisted radical prostatectomy (RARP) including the timing of catheter removal, and to study the relationship of urinary retention with early continence outcomes following RARP, which has never been mentioned in the literature before.
METHODS: 740 consecutive underwent RARP by 2 experienced surgeons at our institute were reviewed retrospectively from a prospectively-collected database. Multiple factors including age, body mass index (BMI), international prostatic symptom score (IPSS), prostate volume, presence of median lobe, nerve preservation, anastomosis time, and catheter removal time (day 4 vs 7) were evaluated as risk factors for AUR using univariate and multivariate analysis. The relation between AUR and early return of continence (1 and 3 months) post-RARP was also evaluated.
RESULTS: The incidence of clinically significant vesicourethral anastomotic leak and AUR following catheter removal were 0.9% and 2.2% (17/740), respectively. In men who developed AUR, there was no significant relationship with regards to age, BMI, IPSS, prostatic volume, median lobe presence, nerve preservation or anastomosis time. Moreover, the incidence of AUR was significantly higher (p¼0.004) for men with catheter removal at day 4 (4.5% (16/351)) vs day 7 (0.2% (1/289)). Moreover, patients with early removal of catheter (day 4) whom developed AUR had earlier 1 month return of 0-pad continence 87.5% (14/16) compared to patients without AUR 45.6% (153/335), with no significant deference at 3 months.
CONCLUSIONS: While AUR is an uncommon complication of RARP, its incidence is much higher than VUA leakage and often not discussed during patient counseling. Early catheter removal at day 4 post RARP is associated with higher incidence of AUR. Moreover, men experiencing AUR were observed to have a much earlier return of urinary continence. Future studies are warranted to validate the impact of AUR on long term outcome of continence. METHODS: Between September 2008 and January 2016, 712 patients underwent radical prostatectomy (RP; 614 LRP and 98 RARP). Recovery of Incontinence was evaluated through a 24-hour pad test. Urinary and erectile function was evaluated using the International Prostate Symptom Score (IPSS) and the International Index of Erectile Function-5 (IIEF-5). Follow-up interval was 1, 3, 6, and 12 months after the surgery. The propensity score (PS) matching was used to balance the pre-operative characteristics. Vol. 197, No. 4S, Supplement, Tuesday, May 16, 2017 THE JOURNAL OF UROLOGY â e1237
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